CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Nick Saban has strong reaction ...

Every face is unique. Genetics helps to determine our features, but sometimes genes have errors which, in early fetal ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...